Shaanxi Kanghui Pharmaceutical Co., Ltd.
SSE:603139.SS
26.2 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 97.6 | 163.755 | 226.273 | 203.96 | 194.911 | 295.702 | 220.185 | 232.913 | 161.559 | 66.952 | 54.913 | 46.998 | 45.37 |
| Short Term Investments
| 0.359 | 3.02 | 4.502 | 119.468 | 55.47 | 192 | -7.81 | 251.983 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 97.959 | 166.774 | 230.774 | 323.427 | 250.38 | 487.702 | 220.185 | 232.913 | 161.559 | 66.952 | 54.913 | 46.998 | 45.37 |
| Net Receivables
| 245.66 | 281.627 | 208.811 | 220.325 | 177.666 | 218.56 | 282.249 | 301.05 | 291.434 | 279.627 | 0 | 159.249 | 99.11 |
| Inventory
| 195.493 | 199.346 | 122.767 | 119.893 | 97.032 | 98.523 | 100.702 | 79.727 | 59.737 | 59.599 | 61.644 | 60.779 | 82.258 |
| Other Current Assets
| 59.859 | 60.477 | 36.809 | 40.196 | 15.28 | 14.456 | 307.892 | 263.4 | 4.321 | 31.739 | 253.584 | 48.121 | 5.577 |
| Total Current Assets
| 598.97 | 708.225 | 580.931 | 666.589 | 540.359 | 819.241 | 911.028 | 877.089 | 517.051 | 437.917 | 370.142 | 315.147 | 232.315 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 976.693 | 982.347 | 948.093 | 827.934 | 471.666 | 141.286 | 70.91 | 60.658 | 56.673 | 60.123 | 64.089 | 64.467 | 37.42 |
| Goodwill
| 18.825 | 15.115 | 15.115 | 19.981 | 19.981 | 15.115 | 15.115 | 15.115 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 99.255 | 103.294 | 113.305 | 130.44 | 134.015 | 70.311 | 73.114 | 75.777 | 63.666 | 65.579 | 34.772 | 36.191 | 37.969 |
| Goodwill and Intangible Assets
| 118.08 | 118.408 | 128.42 | 150.421 | 153.996 | 85.425 | 88.229 | 90.891 | 63.666 | 65.579 | 34.772 | 36.191 | 37.969 |
| Long Term Investments
| 51.011 | 91.454 | 115.609 | 56.462 | 57.812 | -139.3 | 22.578 | 0.09 | 0 | 0 | -0 | 0 | 0 |
| Tax Assets
| 34.43 | 21.194 | 13.328 | 4.853 | 4.05 | 3.853 | 3.761 | 2.797 | 2.61 | 2.607 | 1.895 | 1.412 | 0.824 |
| Other Non-Current Assets
| 108.658 | 130.097 | 35.318 | 153.97 | 83.331 | 220.174 | 13.683 | 0.282 | 14.97 | 12.173 | 36.751 | 32.781 | 7.214 |
| Total Non-Current Assets
| 1,288.872 | 1,343.499 | 1,240.768 | 1,193.64 | 770.856 | 311.438 | 199.16 | 154.718 | 137.919 | 140.482 | 137.507 | 134.85 | 83.426 |
| Total Assets
| 1,887.842 | 2,051.724 | 1,821.699 | 1,860.229 | 1,311.215 | 1,130.678 | 1,110.189 | 1,031.808 | 654.97 | 578.399 | 507.648 | 449.997 | 315.741 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 230.109 | 259.311 | 155.552 | 171.648 | 104.101 | 47.777 | 52.615 | 46.489 | 50.788 | 53.935 | 50.669 | 42.468 | 36.381 |
| Short Term Debt
| 187.51 | 200.559 | 83.845 | 18.644 | 14.54 | 15.96 | 0 | 5 | -0.41 | 41.094 | 35.4 | 28.5 | 45 |
| Tax Payables
| 9.307 | 18.576 | 7.871 | 5.671 | 6.148 | 9.412 | 28.317 | 29.164 | 33.715 | 19.007 | 15.851 | 12.885 | 6.938 |
| Deferred Revenue
| 0 | 0 | 7.954 | 53.58 | 40.377 | 32.302 | 28.317 | 48.706 | 40.897 | 25.372 | 22.048 | 33.362 | 18.598 |
| Other Current Liabilities
| 171.323 | 228.47 | 106.497 | 109.105 | 54.183 | 32.414 | 39.749 | 22.788 | 7.182 | 6.366 | 6.197 | 24.142 | 15.705 |
| Total Current Liabilities
| 598.249 | 706.916 | 361.718 | 318.423 | 183.87 | 105.562 | 120.681 | 103.441 | 129.348 | 118.293 | 109.614 | 107.994 | 104.024 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 333.606 | 283.877 | 386.344 | 396.662 | 27.935 | 0 | 0 | 1.85 | 0 | 0 | 0 | 7.4 | 0 |
| Deferred Revenue Non-Current
| 40.741 | 35.247 | 36.013 | 18.464 | 11.953 | 7.167 | 2.381 | 2.595 | 2.809 | 2.528 | 2.661 | 1.971 | 1.29 |
| Deferred Tax Liabilities Non-Current
| 3.734 | 5.009 | 10.801 | 11.654 | 10.977 | 1.125 | 1.094 | 0.051 | 0 | 0 | 0 | -7.4 | 0 |
| Other Non-Current Liabilities
| 4.608 | 0.755 | 0.879 | 0 | 15.493 | 0 | 6.706 | 11.76 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 382.688 | 324.888 | 434.036 | 426.78 | 54.404 | 8.292 | 10.195 | 16.256 | 2.809 | 2.528 | 2.661 | 9.371 | 1.29 |
| Total Liabilities
| 980.937 | 1,031.803 | 795.754 | 745.203 | 238.274 | 113.854 | 130.876 | 119.697 | 132.157 | 120.821 | 112.275 | 117.365 | 105.314 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 99.88 | 99.88 | 99.88 | 99.88 | 99.88 | 99.88 | 99.88 | 99.88 | 74.91 | 74.91 | 74.91 | 74.91 | 66.67 |
| Retained Earnings
| 277.756 | 367.381 | 393.765 | 464.212 | 438.614 | 416.398 | 389.392 | 359.058 | 302.316 | 243.606 | 187.621 | 131.153 | 80.913 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 71.485 | 69.594 | 72.1 | 58.751 | 51.479 | 46.736 | 41.397 | 35.12 | 28.597 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 479.687 | 410.488 | 410.488 | 410.488 | 410.488 | 410.488 | 365.281 | 410.488 | 76.876 | 111.996 | 111.996 | 126.568 | 62.844 |
| Total Shareholders Equity
| 857.322 | 949.234 | 973.727 | 1,046.679 | 1,007.732 | 978.245 | 946.477 | 910.823 | 522.813 | 457.579 | 395.373 | 332.631 | 210.427 |
| Total Equity
| 906.904 | 1,019.921 | 1,025.945 | 1,115.026 | 1,072.941 | 1,016.825 | 979.312 | 912.11 | 522.813 | 457.579 | 395.373 | 332.631 | 210.427 |
| Total Liabilities & Shareholders Equity
| 1,887.842 | 2,051.724 | 1,821.699 | 1,860.229 | 1,311.215 | 1,130.678 | 1,110.189 | 1,031.808 | 654.97 | 578.399 | 507.648 | 449.997 | 315.741 |